期刊文献+

渗出型年龄相关性黄斑变性荧光素眼底血管造影和光学相干断层成像结果分析 被引量:8

下载PDF
导出
摘要 目的评价荧光素眼底血管造影和光学相干断层扫描检查在渗出型年龄相关性黄斑变性(AMD)所致的脉络膜新生血管对视力的影响。方法回顾性分析46例渗出型年龄相关性黄斑变性患者46眼,均采用荧光素眼底血管造影(FFA)和光学相干断层扫描(OCT)检查并相互印证AMD的分型和性质,FFA评估脉络膜新生血管(CNV)面积,OCT评估其厚度,统计分析其与视力的相关关系。结果 46眼中视力为0.17±0.17,渗漏面积为(4.05±4.88)mm2,CNV的厚度为(321.47±201.82)μm2,运用双变量相关分析显示,视力和渗漏面积的Pearson的R=-0.342,P=0.02,差异具有统计学意义,两者为负相关。视力和CNV的厚度Pearson的R=-0.309,P=0.04,差异具有统计学意义,两者为负相关。结论 FFA诊断CNV的渗漏面积有临床意义,面积与视力成反比;OCT诊断CNV的厚度有临床意义,厚度与视力成反比。
出处 《中国中医眼科杂志》 2010年第5期298-299,共2页 China Journal of Chinese Ophthalmology
  • 相关文献

参考文献3

二级参考文献20

  • 1Macular Photocogulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol, 1991, 109: 1242-1257.
  • 2Treatment of Age-related Macular Degeneration with Photodynamic Therapy(TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol,1999,117:1329-1345.
  • 3TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol,2001,119:198-207.
  • 4VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in p
  • 5VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia:2-year results of a randomized clinical trial-VIP report No.3.Ophthalmology,2003,110:667-673.
  • 6Rogers AH, Duker JS, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology,2003,110:1315-1320.
  • 7Schmidt-Erfurth UM, Michels S. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Ophthalmology, 2003, 110: 1306-1314.
  • 8Schmidt-Erfurth U, Laqua H, Schlotzer- Schrehard U, et al. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol, 2002,120:835-844.
  • 9American Academy of Ophthalmology. Photodynamic therapy with verteporfin for age-related macular degeneration. Ophthalmology, 2000,107:2314-2317.
  • 10Iida T et al. American Journal of Ophthalmology . 1998

共引文献66

同被引文献61

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部